These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 2972271)

  • 1. Immunogenicity study of a plasma-derived heat-inactivated hepatitis-B vaccine in newborn babies: a randomised dose-response study.
    Ip HM; Wong VC; Reesink HW; Lelie PN; Yeung CY; Ma HK
    Asia Oceania J Obstet Gynaecol; 1988 Sep; 14(3):367-71. PubMed ID: 2972271
    [No Abstract]   [Full Text] [Related]  

  • 2. Lack of immune potentiation by complexing HBsAg in a heat-inactivated hepatitis B vaccine with antibody in hepatitis B immunoglobulin.
    Lelie PN; van Amelsfoort PJ; Martine de Groot CS; Bakker E; Schaasberg W; Niessen JC; Reesink HW
    Hepatology; 1989 Jul; 10(1):36-8. PubMed ID: 2737602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dose range study in healthy volunteers of a hepatitis B vaccine produced in yeast.
    Kuwert E; Scheiermann N; Gesemann M; Paar D; Safary A; Simoen E; Hauser P; Andre F
    Antiviral Res; 1985; Suppl 1():281-8. PubMed ID: 2935080
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunogenicity of hepatitis B vaccine in Chinese school children: a comparison of two plasma-derived vaccines.
    Lee SD; Lo KJ; Tsai YT; Chan CY; Wu TC; Hwang SJ; Chang CP; Huang YS
    Zhonghua Yi Xue Za Zhi (Taipei); 1988 Aug; 42(2):87-92. PubMed ID: 3066454
    [No Abstract]   [Full Text] [Related]  

  • 5. Is nonresponsiveness to hepatitis B vaccine due to latent hepatitis B virus infection?
    Luo KX; Wang LP; Nie J; Jiang S
    J Infect Dis; 1992 Apr; 165(4):777-8. PubMed ID: 1532408
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunogenicity and side effects of low dose intradermally administered hepatitis B vaccine.
    Pathak UN; Dilawari JB; Chawla Y; Sokhey CS; Sharma BK; Ganguly NK
    Indian J Gastroenterol; 1988 Apr; 7(2):113-4. PubMed ID: 2966113
    [No Abstract]   [Full Text] [Related]  

  • 7. Antibody response to heat-inactivated hepatitis B vaccine (CLB-3 micrograms) in hemodialysis patients and occupational risk personnel: a one year follow-up.
    Yoshida FT; Takahashi C; Mercadante LA; Camargo IF; Schatzmayr HG
    Rev Inst Med Trop Sao Paulo; 1988; 30(1):11-6. PubMed ID: 2975824
    [No Abstract]   [Full Text] [Related]  

  • 8. Reactogenicity and immunogenicity of a new recombinant yeast-derived hepatitis B vaccine.
    Scheiermann N; Gesemann KM; Paar D; Maurer C
    Zentralbl Bakteriol Mikrobiol Hyg A; 1988 Nov; 269(3):411-21. PubMed ID: 2975448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma-derived versus recombinant hepatitis B vaccines.
    Kurtz JB; Alder MJ; Mayon-White RT; Juel-Jensen BE; Rodgers TM; Babic GM
    Lancet; 1989 Feb; 1(8635):451. PubMed ID: 2563836
    [No Abstract]   [Full Text] [Related]  

  • 10. Immune response to hepatitis B vaccine in premature neonates.
    Chawareewong S; Jirapongsa A; Lokaphadhana K
    Southeast Asian J Trop Med Public Health; 1991 Mar; 22(1):39-40. PubMed ID: 1835140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune response to hepatitis B vaccine in subjects positive for serum hepatitis B core antibody alone.
    Wu JS; Tam KM
    Taiwan Yi Xue Hui Za Zhi; 1988 Oct; 87(10):944-7. PubMed ID: 3241153
    [No Abstract]   [Full Text] [Related]  

  • 12. Duration of immune protection after hepatitis B vaccine in newborns from HBsAg-positive carrier mothers.
    Belloni C; Orsolini P; Soldini L; Campisi D; Chiesa A; Ciceri R; Filice G
    Microbiologica; 1991 Jul; 14(3):195-8. PubMed ID: 1833611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Response to hepatitis B vaccine in family members of HBsAg carriers.
    Lok AS; Lai CL; Wu PC; Ng MM
    J Med Virol; 1986 May; 19(1):33-9. PubMed ID: 2939197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Active pre-exposure immunisation against hepatitis B virus: immunogenicity of hepatitis B vaccine in healthy Thai adults and children.
    Pongpipat D; Suvatte V; Assateerawatts A; Bhethraratt S
    Asian Pac J Allergy Immunol; 1987 Jun; 5(1):63-5. PubMed ID: 2956961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogenicity of yeast-derived hepatitis B vaccine from two different producers.
    Dahl-Hansen E; Siebke JC; Frøland SS; Degré M
    Epidemiol Infect; 1990 Feb; 104(1):143-9. PubMed ID: 2137785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two-year study of passive-active immunization for prevention of hepatitis B infection in newborns.
    Theppisai U; Thanuntaseh C; Chiewsilp P; Siripoonya P
    J Med Assoc Thai; 1988 Aug; 71(8):413-6. PubMed ID: 2978040
    [No Abstract]   [Full Text] [Related]  

  • 17. Novel hepatitis B vaccines.
    Zuckerman AJ
    J Infect; 1986 Jul; 13 Suppl A():61-71. PubMed ID: 2427591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunogenicity of a combined hepatitis A and B vaccine in healthy young adults.
    Knöll A; Hottenträger B; Kainz J; Bretschneider B; Jilg W
    Vaccine; 2000 Apr; 18(19):2029-32. PubMed ID: 10706965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prolonged immunity after late booster doses of hepatitis B vaccine.
    Jilg W; Schmidt M; Deinhardt F
    J Infect Dis; 1988 Jun; 157(6):1267-9. PubMed ID: 2967336
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunogenicity of hepatitis B vaccine in patients infected with Schistosoma mansoni.
    Bassily S; Hyams KC; el-Ghorab NM; Mansour MM; el-Masry NA; Dunn MA
    Am J Trop Med Hyg; 1987 May; 36(3):549-53. PubMed ID: 2953263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.